Goldman Sachs Raises JCET Group Target Price to 125 Yuan, Maintains Neutral Rating
N.R. Finch
Goldman Sachs more than doubled its target price on JCET (长电科技, 600584) from ¥50.9 to ¥125 — yet kept the stock at neutral. This means the bank is not turning outright bullish; it has shifted its valuation anchor from near-term earnings to a 2030 discounted P/E, with short-term profit pressure still the central concern.
Why double the target yet withhold a "buy"?
Goldman anchors to a 46× 2030 estimated P/E, then discounts back to 2027 to arrive at ¥125. This means → the bank sees JCET's full value emerging only around 2030 — buying now requires more than three years of patience.
The key assumptions behind that number: sustained net-profit growth through 2031, operating margin approaching 10%, and a much higher share of revenue from AI advanced packaging. In plain terms = Goldman has sketched a "JCET becomes an AI packaging platform" scenario, but stamped it "not yet delivered."
Neutral rating signals Goldman believes the market still needs to see expenses, depreciation, and gross margin actually materialize before the thesis pays off.
Why is profit under pressure near-term but set to improve later?
2026–2027 earnings face headwinds from rising R&D spending on AI-chip OSAT (outsourced semiconductor assembly and test) and yield-ramp costs — the expenses and depreciation that come with bringing a new production line from commissioning to stable output.
From 2028, profits could be revised upward as AI-chip advanced packaging — using precision processes to bond multiple chips together — scales up and gross margins improve. This means → the next two years are a "spending phase"; the payoff is at least one more year away.
JCET's reported 2025 R&D spending hit ¥2.086 bn, up 21.37% year-on-year, far outpacing revenue growth of 8.09%. This reflects a company trading current profit for future capacity.
What does the subsidiary split reveal?
Jiangyin JCET Advanced Packaging: 2025 revenue of ¥2.158 bn, net profit of ¥585 mn, high utilization, full order book — the proven, money-making asset today.
JCET Microelectronics: revenue just ¥204 mn, net loss of ¥192 mn, still in early-stage ramp for high-end advanced packaging. In plain terms = this is the highest-optionality variable in Goldman's model — if it scales and narrows losses, the platform re-rating story solidifies; if spending continues without margin improvement, the market will revert to a heavy-asset OSAT discount.
JCET Auto Electronics: still in construction phase with losses through 2025, formal line-start at year-end, volume ramp beginning in 2026 — another increment awaiting proof.
Why do the three major banks disagree?
Goldman Sachs: long-dated discounted valuation, neutral, emphasizing near-term profit pressure — "the destination is visible, but the road is long."
J.P. Morgan: upgraded JCET from neutral to overweight on June 16, arguing that AI-related revenue, capex efficiency, and high-end utilization could improve together. This means → JPM believes the inflection point may arrive earlier than Goldman expects.
UBS: frames JCET through a localization lens, positioning it in the advanced-packaging beneficiary chain tied to domestic AI-chip mass production. Its re-rating logic is directly linked to the pace of China's homegrown AI-chip ramp.
What to watch over the next four quarters?
JCET Microelectronics P&L trajectory: whether losses narrow and revenue scales will determine if the "platform" narrative holds up.
Advanced-packaging gross margin: Goldman's model is highly sensitive to this input — any deviation materially changes the discounted target price.
Order visibility behind capex and operating cash-flow quality: whether the money being spent maps to real orders, and whether cash flow can keep pace with expansion. In plain terms = these four items are the hard exam that decides whether JCET graduates from "contract packager" to "AI packaging platform."
Content is for reference only, not financial advice.